rs7637863

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000340.2(SLC2A2):​c.203C>T​(p.Pro68Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00476 in 1,613,978 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 19 hom. )

Consequence

SLC2A2
NM_000340.2 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.15

Publications

14 publications found
Variant links:
Genes affected
SLC2A2 (HGNC:11006): (solute carrier family 2 member 2) This gene encodes an integral plasma membrane glycoprotein of the liver, islet beta cells, intestine, and kidney epithelium. The encoded protein mediates facilitated bidirectional glucose transport. Because of its low affinity for glucose, it has been suggested as a glucose sensor. Mutations in this gene are associated with susceptibility to diseases, including Fanconi-Bickel syndrome and noninsulin-dependent diabetes mellitus (NIDDM). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]
SLC2A2 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to GLUT2 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, G2P
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • transient neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0051350296).
BP6
Variant 3-171014637-G-A is Benign according to our data. Variant chr3-171014637-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 516406.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00334 (508/152164) while in subpopulation NFE AF = 0.00535 (364/68012). AF 95% confidence interval is 0.0049. There are 2 homozygotes in GnomAd4. There are 225 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC2A2NM_000340.2 linkc.203C>T p.Pro68Leu missense_variant Exon 3 of 11 ENST00000314251.8 NP_000331.1 P11168-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC2A2ENST00000314251.8 linkc.203C>T p.Pro68Leu missense_variant Exon 3 of 11 1 NM_000340.2 ENSP00000323568.3 P11168-1

Frequencies

GnomAD3 genomes
AF:
0.00333
AC:
506
AN:
152046
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00535
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00382
AC:
961
AN:
251468
AF XY:
0.00381
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00295
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000979
Gnomad FIN exome
AF:
0.00337
Gnomad NFE exome
AF:
0.00612
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00490
AC:
7169
AN:
1461814
Hom.:
19
Cov.:
32
AF XY:
0.00475
AC XY:
3452
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.000777
AC:
26
AN:
33478
American (AMR)
AF:
0.00284
AC:
127
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.00154
AC:
61
AN:
39698
South Asian (SAS)
AF:
0.000985
AC:
85
AN:
86256
European-Finnish (FIN)
AF:
0.00344
AC:
184
AN:
53420
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.00581
AC:
6460
AN:
1111944
Other (OTH)
AF:
0.00354
AC:
214
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
377
754
1131
1508
1885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00334
AC:
508
AN:
152164
Hom.:
2
Cov.:
32
AF XY:
0.00303
AC XY:
225
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41512
American (AMR)
AF:
0.00288
AC:
44
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5178
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4816
European-Finnish (FIN)
AF:
0.00255
AC:
27
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00535
AC:
364
AN:
68012
Other (OTH)
AF:
0.00520
AC:
11
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00381
Hom.:
0
Bravo
AF:
0.00346
TwinsUK
AF:
0.00620
AC:
23
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00488
AC:
42
ExAC
AF:
0.00423
AC:
514
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00425
EpiControl
AF:
0.00474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Aug 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ENSG00000286856: BS2; SLC2A2: BP4, BS2 -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
Mar 07, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Fanconi-Bickel syndrome Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Monogenic diabetes Benign:1
Jan 18, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BS1 (MAF 0.6% in EurNF in gnomAD), BS2 (4 homozygotes in ExAC, 50 cases and 41 controls in type2diabetesgenetics.org), BS3 (PMID 23986439 shows our variant has similar expression, localization and size compared to WT protein): benign (REVEL 0.289 + PP3/3 predictors + BP4/8 predictors: conflicting evidence, not using) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
14
DANN
Benign
0.72
DEOGEN2
Benign
0.36
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.91
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.59
T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.0051
T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
0.81
L
PhyloP100
1.1
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.88
N
REVEL
Benign
0.29
Sift
Benign
0.039
D
Sift4G
Benign
0.070
T
Polyphen
0.0010
B
Vest4
0.11
MVP
0.69
MPC
0.16
ClinPred
0.0037
T
GERP RS
3.7
Varity_R
0.047
gMVP
0.47
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7637863; hg19: chr3-170732426; COSMIC: COSV105195869; API